课题基金 / 基金详情

Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit

Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
蛋白质组学研究旨在了解卵巢肿瘤对针对 DNA 损伤反应的药物的反应,并将这些知识转化为临床益处
批准号:
10287121
负责人:
Michael Birrer
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-06-01 至 2022-03-31

项目摘要

项目成果

Michael Birrer的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 我们将为阿尔茨海默病(AD)社区提供一种基于高级 能够对先天免疫进行精确、高度特异、标准化、多重量化的方法- 阿尔茨海默病脑组织中的补体蛋白网络先天免疫反应及其与炎症的联系是 对阿尔茨海默病的病理生理学很重要,是一个可行的治疗靶点。免疫调节 系统是许多100种蛋白质相互作用的结果,以及传统的蛋白质定量 方法(例如免疫分析)通常一次只针对一种分析物,这不足以研究 复杂而强大的信号网络的行为,如先天免疫。我们将开发多种检测方法 为了量化先天免疫网络中的蛋白质,使用基于 靶向形式的质谱学称为多反应监测(MRM)。所有分析方案和验证 数据将通过建立的、开源的NCI作为一种新的资源向社区公开提供 分析门户网站(assays.ancer.gov)。我们认为,这项工作可能会刺激额外的工作,从而导致 基于先进方法学为AD社区提供新的检测资源的AD研究进展 这使炎症/先天炎症的精确、高度特异、可标准化、多重量化成为可能 阿尔茨海默病脑内的免疫蛋白网络。
英文摘要
ABSTRACT We will provide the Alzheimer’s disease (AD) community with a novel assay resource based on advanced methodology that enables precise, highly specific, standardizable, multiplex quantification of the innate immunity- complement protein network in AD brain tissues. The innate immune response and its ties to inflammation are important to the pathophysiology of AD and represents a viable therapeutic target. Regulation of the immune system is the result of interplay amongst many 100s of proteins, and conventional protein quantification approaches (e.g. immunoassays) typically target one analyte at a time, which is not adequate for studying the behavior of a complex and robust signaling network such as innate immunity. We will develop multiplex assays to quantify proteins in the innate immune network, using a NextGen protein quantification platform based on a targeted form of mass spectrometry called multiple reaction monitoring (MRM). All assay protocols and validation data will be made publicly available as a novel resource to the community via the established, open-source NCI Assay Portal (assays.cancer.gov). We believe that this work is likely to stimulate additional work leading to progress on AD by providing the AD community with a novel assay resource based on advanced methodology that enables precise, highly specific, standardizable, multiplex quantification of the inflammation / innate immunity protein network in AD brains.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proteomic, Genomic, and Longitudinal Pathways to Ovarian Cancer Biomarker Discovery
  • 批准号:
    10426776
  • 项目类别:
  • 资助金额:
    $8.3万
  • 财政年份:
    2021
  • 负责人:
    Michael Birrer
  • 依托单位:
Validation of a genomic signature that predicts for sub-optimal debulking of epithelial ovarian cancer
  • 批准号:
    10150186
  • 项目类别:
  • 资助金额:
    $9.6万
  • 财政年份:
    2018
  • 负责人:
    Michael Birrer
  • 依托单位:
Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
  • 批准号:
    10602812
  • 项目类别:
  • 资助金额:
    $95.13万
  • 财政年份:
    2017
  • 负责人:
    Michael Birrer
  • 依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究